Zurcher Kantonalbank (Zurich Cantonalbank) Aclaris Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$0.64 - $6.49 $15,018 - $152,300	23,467 Added 115.5%	43,784 $45,000
Q3 2023 Oct 25, 2023	BUY	$6.56 - $10.95 $39,845 - $66,510	6,074 Added 42.65%	20,317 $139,000
Q2 2023 Aug 07, 2023	BUY	$7.89 - $10.64 $35,378 - $47,709	4,484 Added 45.95%	14,243 $147,000
Q4 2022 Feb 01, 2023	BUY	$14.33 - $18.37 $32,357 - $41,479	2,258 Added 30.1%	9,759 $153,000
Q4 2021 Feb 01, 2022	BUY	$12.27 - $18.49 $52,638 - $79,322	4,290 Added 133.6%	7,501 $109,000
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $42,963 - $60,366	3,211 New	3,211 $58,000
Q2 2019 Jul 30, 2019	SELL	$2.13 - $7.06 $3,872 - $12,835	-1,818 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$21.47 - $27.8 $11,099 - $14,372	517 Added 39.74%	1,818 $45,000
Q3 2017 Nov 08, 2017	BUY	$23.02 - $28.8 $29,949 - $37,468	1,301	1,301 $34,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account